The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection

Global Meningococcal Initiative: guidelines for diagnosis and confirmation of invasive meningococcal disease

(2016) J. A. VÁZQUEZ et al.   EPIDEMIOLOGY AND INFECTION

Meningococcal carriage rates in healthy individuals in Japan determined using Loop-Mediated Isothermal Amplification and oral throat wash specimens

(2016) Hideyuki Takahashi et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Global epidemiology of capsular group W meningococcal disease (1970–2015): Multifocal emergence and persistence of hypervirulent sequence type (ST)-11 clonal complex

(2016) Mustapha M. Mustapha et al.   VACCINE

Evolutionary Events Associated with an Outbreak of Meningococcal Disease in Men Who Have Sex with Men

(2016) Muhamed-Kheir Taha et al.   PLoS One

Bivalent rLP2086 Vaccine (Trumenba®): A Review in Active Immunization Against Invasive Meningococcal Group B Disease in Individuals Aged 10–25 Years

(2015) Matt Shirley et al.   BIODRUGS

Risk of invasive meningococcal disease in children and adults with HIV in England: a population-based cohort study

(2015) Ruth D. Simmons et al.   BMC Medicine

Characterization of invasive Neisseria meningitidis strains from Québec, Canada, during a period of increased serogroup B disease, 2009-2013: phenotyping and genotyping with special emphasis on the non-carbohydrate protein vaccine targets

(2015) Dennis K.S. Law et al.   BMC MICROBIOLOGY

Modeling Long-term Vaccination Strategies With MenAfriVac in the African Meningitis Belt

(2015) Andromachi Karachaliou et al.   CLINICAL INFECTIOUS DISEASES

Meningococcal Meningitis Surveillance in the African Meningitis Belt, 2004–2013

(2015) Clément Lingani et al.   CLINICAL INFECTIOUS DISEASES

Neisseria meningitidis: pathogenesis and immunity

(2015) Mariagrazia Pizza et al.   CURRENT OPINION IN MICROBIOLOGY

Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage

(2015) Jay Lucidarme et al.   JOURNAL OF INFECTION

Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategy

(2015) Catherine A. Jeppesen et al.   JOURNAL OF INFECTION

Present situation and challenges of vaccinations for overseas travelers from Japan

(2015) Atsuo Hamada et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Prevalence, Risk Factors and Molecular Characteristics of Meningococcal Carriage Among Brazilian Adolescents

(2015) Jose Cassio de Moraes et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

First Use of a Serogroup B Meningococcal Vaccine in the US in Response to a University Outbreak

(2015) L. A. McNamara et al.   PEDIATRICS

MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine

(2015) Duccio Medini et al.   VACCINE

The current situation of meningococcal disease in Latin America and updated Global Meningococcal Initiative (GMI) recommendations

(2015) Marco Aurélio P. Sáfadi et al.   VACCINE

Impact of vaccination on meningococcal epidemiology

(2015) Paola Stefanelli et al.   Human Vaccines & Immunotherapeutics

Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015

(2015) Jessica R. MacNeil et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Genomic Epidemiology of Hypervirulent Serogroup W, ST-11 Neisseria meningitidis

(2015) Mustapha M. Mustapha et al.   EBioMedicine

Increase in Endemic Neisseria meningitidis Capsular Group W Sequence Type 11 Complex Associated With Severe Invasive Disease in England and Wales

(2014) Shamez N. Ladhani et al.   CLINICAL INFECTIOUS DISEASES

Neisseria meningitidis; clones, carriage, and disease

(2014) R.C. Read   CLINICAL MICROBIOLOGY AND INFECTION

Serogroup W meningococcal disease: global spread and current affect on the Southern Cone in Latin America

(2014) R. ABAD et al.   EPIDEMIOLOGY AND INFECTION

Evolving meningococcal immunization strategies

(2014) Marco Aurélio Sáfadi et al.   Expert Review of Vaccines

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial

(2014) Robert C Read et al.   LANCET

Emergencia de la cepa W135 causante de enfermedad meningocócica invasora en Chile 2012

(2014) M. Teresa Valenzuela et al.   REVISTA MEDICA DE CHILE

Meningococcal Disease: Epidemiology and Early Effects of Immunization Programs

(2014) M. A. P. Safadi et al.   Journal of the Pediatric Infectious Diseases Society

The current situation of meningococcal disease in Latin America and recommendations for a new case definition from the Global Meningococcal Initiative

(2013) Marco Aurélio P Sáfadi et al.   Expert Review of Vaccines

Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials

(2013) Timo Vesikari et al.   LANCET

Effect of a serogroup A meningococcal conjugate vaccine (PsA–TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study

(2013) DM Daugla et al.   LANCET

An overview of meningococcal disease in India: Knowledge gaps and potential solutions

(2013) T. Jacob John et al.   VACCINE

Introducing vaccination against serogroup B meningococcal disease: An economic and mathematical modelling study of potential impact

(2013) Hannah Christensen et al.   VACCINE

Effectiveness of meningococcal serogroup C vaccine programmes

(2013) Ray Borrow et al.   VACCINE

Impact of MenBvac, an outer membrane vesicle (OMV) vaccine, on the meningococcal carriage

(2013) Valérie Delbos et al.   VACCINE

Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): Lessons from past programs and implications for the future

(2013) Johan Holst et al.   Human Vaccines & Immunotherapeutics

An epidemiological review of changes in meningococcal biology during the last 100 years

(2013) Anne Abio et al.   Pathogens and Global Health

Second hand smoke exposure and the risk of invasive meningococcal disease in children: systematic review and meta-analysis

(2012) Rachael L Murray et al.   BMC PUBLIC HEALTH

Impact of the Serogroup A Meningococcal Conjugate Vaccine, MenAfriVac, on Carriage and Herd Immunity

(2012) Paul A. Kristiansen, Fabien Diomandé, Absatou Ky Ba, Idrissa Sanou, Abdoul–Salam Ouédraogo, Rasmata Ouédraogo, Lassana Sangaré, Denis Kandolo, Flavien Aké, Inger Marie Saga, Thomas A. Clark, Lara Misegades, Stacey W. Martin, Jennifer Dolan Thomas, Sylvestre R. Tiendrebeogo, Musa Hassan-King, Mamoudou H. Djingarey, Nancy E. Messonnier, Marie-Pierre Préziosi, F. Marc LaForce, Dominique A. Caugant   CLINICAL INFECTIOUS DISEASES

Molecular Characterization of Invasive Meningococcal Isolates from Countries in the African Meningitis Belt before Introduction of a Serogroup A Conjugate Vaccine

(2012) Dominique A. Caugant et al.   PLoS One

Meningococcal disease: Clinical presentation and sequelae

(2012) David Pace et al.   VACCINE

Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?

(2012) Eva Hong et al.   VACCINE

The changing epidemiology of meningococcal disease in North America 1945–2010

(2012) Carmen Baccarini et al.   Human Vaccines & Immunotherapeutics

The Global Meningococcal Initiative: Recommendations for reducing the global burden of meningococcal disease

(2011) Lee H. Harrison et al.   VACCINE

The changing and dynamic epidemiology of meningococcal disease

(2011) Scott A. Halperin et al.   VACCINE

Increased incidence of meningococcal disease in HIV-infected individuals associated with higher case-fatality ratios in South Africa

(2010) Cheryl Cohen et al.   AIDS

Phenotypic and molecular characterization of invasive serogroup W135 Neisseria meningitidis strains from 1990 to 2005 in Brazil

(2010) Ana Paula S. Lemos et al.   JOURNAL OF INFECTION

Meningococcal Disease: The Organism, Clinical Presentation, and Worldwide Epidemiology

(2010) Jaffar A. Al‐Tawfiq et al.   JOURNAL OF TRAVEL MEDICINE

Meningococcal carriage by age: a systematic review and meta-analysis

(2010) Hannah Christensen et al.   LANCET INFECTIOUS DISEASES

Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines

(2010) J. Donnelly et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Changes inNeisseria meningitidisDisease Epidemiology in the United States, 1998–2007: Implications for Prevention of Meningococcal Disease

(2009) Amanda C. Cohn et al.   CLINICAL INFECTIOUS DISEASES

Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs

(2009) Caroline L Trotter et al.   Expert Review of Vaccines

Meningococcal carriage and disease—Population biology and evolution

(2009) Dominique A. Caugant et al.   VACCINE

Emergence of Endemic Serogroup W135 Meningococcal Disease Associated with a High Mortality Rate in South Africa

(2008) A. von Gottberg et al.   CLINICAL INFECTIOUS DISEASES

High prevalence of Neisseria meningitidis hypervirulent lineages and emergence of W135:P1.5,2:ST-11 clone in Southern Brazil

(2008) Luciana Weidlich et al.   JOURNAL OF INFECTION

Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity

(2008) Martin C. J. Maiden et al.   JOURNAL OF INFECTIOUS DISEASES

Neisseria meningitidis serogroup W135 in Portugal: Presence of the ST-11/ET-37 clonal complex

(2008) E. Ferreira et al.   PATHOLOGIE BIOLOGIE